tm logo
SERMONIX PHARMACEUTICALS
Live/Registered
REGISTERED

on 23 Jan 2024

Last Applicant/ Owned by

250 East Broad Street, Suite 250

Columbus

OH

43215

Serial Number

88681480 filed on 05th Nov 2019

Registration Number

7287506 registered on 23rd Jan 2024

in the Principal Register

Correspondent Address

Karen A. Webb, Esq.

Karen A. Webb, Esq.

801 CALIFORNIA STREET

SILICON VALLEY CENTER

MOUNTAIN VIEW,CA 94041-1990

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SERMONIX PHARMACEUTICALS

Pharmaceutical preparation for post-menopausal women's health, namely, to prevent and treat breast cancer, osteoporosis and vulvovaginal atrophy

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparation for post-menopausal women's health, namely, to prevent and treat breast cancer, osteoporosis and vulvovaginal atrophy


First Use Date in General

20th Jun 2023

First Use Date in Commerce

20th Jun 2023

Specimens


SERMONIX PHARMACEUTICALS specimenSERMONIX PHARMACEUTICALS specimen

Mark Details


Serial Number

No 88681480

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 32524-00070

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

02.01.33 -

Grotesque men formed by letters, numbers, punctuation or geometric shapes

26.01.02 -

Plain single line circles

26.01.31 -

Five or more circles

26.17.09 -

Curved line(s), band(s) or bar(s)

26.17.25 -

Other lines, bands or bars

Legal History


Show more

Status DateAction Taken
23rd Jan 2024REGISTERED-PRINCIPAL REGISTER
23rd Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
19th Dec 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Dec 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17th Nov 2023TEAS/EMAIL CORRESPONDENCE ENTERED
16th Nov 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
16th Nov 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
28th Aug 2023SU - NON-FINAL ACTION - WRITTEN
28th Aug 2023NON-FINAL ACTION E-MAILED
28th Aug 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED